IL116176A0 - Intermediate compounds for the diastereoselective synthesis of cis-nucleoside analogues - Google Patents
Intermediate compounds for the diastereoselective synthesis of cis-nucleoside analoguesInfo
- Publication number
- IL116176A0 IL116176A0 IL11617695A IL11617695A IL116176A0 IL 116176 A0 IL116176 A0 IL 116176A0 IL 11617695 A IL11617695 A IL 11617695A IL 11617695 A IL11617695 A IL 11617695A IL 116176 A0 IL116176 A0 IL 116176A0
- Authority
- IL
- Israel
- Prior art keywords
- cis
- nucleoside analogues
- intermediate compounds
- diastereoselective synthesis
- diastereoselective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/06—Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Catalysts (AREA)
- Furan Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Vehicle Step Arrangements And Article Storage (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70337991A | 1991-05-21 | 1991-05-21 | |
IL10193295 | 1995-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL116176A0 true IL116176A0 (en) | 1996-01-31 |
Family
ID=24825144
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL116176A IL116176A (en) | 1991-05-21 | 1992-05-20 | Middle compounds for the diastereoselective synthesis of SIC analogues - nucleoside |
IL101932A IL101932A (en) | 1991-05-21 | 1992-05-20 | Processes for the diastereoselective synthesis of cis-nucleoside analogues |
IL11610992A IL116109A (en) | 1991-05-21 | 1992-05-20 | Intermediates for the preparation of SIC-nucleosides and nucleoside analogues with optical activity |
IL10193192A IL101931A (en) | 1991-05-21 | 1992-05-20 | Processes for the SIC-Nucleoside Diastyrioselective Synthesis and Nucleuside Analogs |
IL11610995A IL116109A0 (en) | 1991-05-21 | 1995-11-23 | Intermediate compounds for the diastereoselective synthesis of cis-nucleosides |
IL11617695A IL116176A0 (en) | 1991-05-21 | 1995-11-28 | Intermediate compounds for the diastereoselective synthesis of cis-nucleoside analogues |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL116176A IL116176A (en) | 1991-05-21 | 1992-05-20 | Middle compounds for the diastereoselective synthesis of SIC analogues - nucleoside |
IL101932A IL101932A (en) | 1991-05-21 | 1992-05-20 | Processes for the diastereoselective synthesis of cis-nucleoside analogues |
IL11610992A IL116109A (en) | 1991-05-21 | 1992-05-20 | Intermediates for the preparation of SIC-nucleosides and nucleoside analogues with optical activity |
IL10193192A IL101931A (en) | 1991-05-21 | 1992-05-20 | Processes for the SIC-Nucleoside Diastyrioselective Synthesis and Nucleuside Analogs |
IL11610995A IL116109A0 (en) | 1991-05-21 | 1995-11-23 | Intermediate compounds for the diastereoselective synthesis of cis-nucleosides |
Country Status (34)
Country | Link |
---|---|
US (5) | US5756706A (xx) |
EP (2) | EP0515156B1 (xx) |
JP (3) | JP3229013B2 (xx) |
KR (3) | KR100232012B1 (xx) |
CN (6) | CN1038591C (xx) |
AT (2) | ATE157662T1 (xx) |
AU (4) | AU1691392A (xx) |
BG (2) | BG61695B1 (xx) |
CA (2) | CA2069024C (xx) |
CZ (3) | CZ285220B6 (xx) |
DE (2) | DE69221936T2 (xx) |
DK (2) | DK0515157T3 (xx) |
EE (1) | EE03044B1 (xx) |
ES (2) | ES2104832T3 (xx) |
FI (3) | FI106377B (xx) |
GR (2) | GR3018941T3 (xx) |
GT (1) | GT199800047A (xx) |
HK (2) | HK132196A (xx) |
HU (2) | HU223838B1 (xx) |
IE (2) | IE76741B1 (xx) |
IL (6) | IL116176A (xx) |
MD (1) | MD1155C2 (xx) |
MX (2) | MX9202404A (xx) |
NO (2) | NO300593B1 (xx) |
NZ (2) | NZ242817A (xx) |
OA (1) | OA10212A (xx) |
PL (3) | PL176026B1 (xx) |
RO (1) | RO116812B1 (xx) |
RU (4) | RU2223960C2 (xx) |
SG (1) | SG43863A1 (xx) |
SK (2) | SK279438B6 (xx) |
TW (4) | TW366349B (xx) |
WO (2) | WO1992020696A1 (xx) |
ZA (2) | ZA923641B (xx) |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US6350753B1 (en) | 1988-04-11 | 2002-02-26 | Biochem Pharma Inc. | 2-Substituted-4-substituted-1,3-dioxolanes and use thereof |
US6903224B2 (en) | 1988-04-11 | 2005-06-07 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes |
US6175008B1 (en) | 1988-04-11 | 2001-01-16 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
PT674634E (pt) * | 1989-02-08 | 2003-09-30 | Iaf Biochem Int | Processos para preparar 1,3-oxatiolanos substituidos com propriedades antivirais |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US6812233B1 (en) | 1991-03-06 | 2004-11-02 | Emory University | Therapeutic nucleosides |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
US6444656B1 (en) | 1992-12-23 | 2002-09-03 | Biochem Pharma, Inc. | Antiviral phosphonate nucleotides |
GB9226879D0 (en) * | 1992-12-23 | 1993-02-17 | Iaf Biochem Int | Anti-viral compounds |
US6005107A (en) | 1992-12-23 | 1999-12-21 | Biochem Pharma, Inc. | Antiviral compounds |
GB9226927D0 (en) * | 1992-12-24 | 1993-02-17 | Iaf Biochem Int | Dideoxy nucleoside analogues |
US5627160A (en) * | 1993-05-25 | 1997-05-06 | Yale University | L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
TW374087B (en) * | 1993-05-25 | 1999-11-11 | Univ Yale | L-2',3'-dideoxy nucleotide analogs as anti-hepatitis B(HBV) and anti-HIV agents |
GB9311709D0 (en) * | 1993-06-07 | 1993-07-21 | Iaf Biochem Int | Stereoselective synthesis of nucleoside analogues using bicycle intermediate |
WO1995007086A1 (en) | 1993-09-10 | 1995-03-16 | Emory University | Nucleosides with anti-hepatitis b virus activity |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL113432A (en) | 1994-04-23 | 2000-11-21 | Glaxo Group Ltd | Process for the diastereoselective synthesis of nucleoside analogues |
GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
IL115156A (en) | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5703058A (en) | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
US5869461A (en) * | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
GB9506644D0 (en) * | 1995-03-31 | 1995-05-24 | Wellcome Found | Preparation of nucleoside analogues |
EP0831852B1 (en) | 1995-06-07 | 2006-11-29 | Emory University | Nucleosides with anti-hepatitis b virus activity |
CN1201463A (zh) * | 1995-11-02 | 1998-12-09 | 株式会社钟根堂 | 新型核苷衍生物及其制备方法 |
GB9600143D0 (en) | 1996-01-05 | 1996-03-06 | Wellcome Found | Therapeutic compounds |
EP0799834A1 (en) * | 1996-04-04 | 1997-10-08 | Novartis AG | Modified nucleotides |
US6005097A (en) * | 1996-06-14 | 1999-12-21 | Vion Pharmaceuticals, Inc. | Processes for high-yield diastereoselective synthesis of dideoxynucleosides |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
US6022876A (en) | 1996-11-15 | 2000-02-08 | Yale University | L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
DE69819695D1 (en) | 1997-02-13 | 2003-12-18 | Glaxo Group Ltd | Benzimidazolderivate |
JP2001518899A (ja) | 1997-04-07 | 2001-10-16 | トライアングル ファーマシューティカルズ,インコーポレイティド | 他の抗ウイルス剤との組合せにおけるmkc−442の使用 |
DK0994890T3 (da) | 1997-06-10 | 2003-12-01 | Univ Michigan | Benzimidazolderivater |
NZ502882A (en) | 1997-07-30 | 2002-02-01 | Glaxo Group Ltd | Lyxofuranosyl benzimidazoles as antiviral agents |
US20030220234A1 (en) * | 1998-11-02 | 2003-11-27 | Selvaraj Naicker | Deuterated cyclosporine analogs and their use as immunodulating agents |
YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
EP1535921A1 (en) | 1998-08-12 | 2005-06-01 | Gilead Sciences, Inc. | Method of manufacture of 1,3-oxathiolane nucleosides |
US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
DK1140937T3 (da) | 1998-12-23 | 2004-03-22 | Shire Biochem Inc | Antivirale nucleosid-analoger |
US7635690B2 (en) | 1999-01-22 | 2009-12-22 | Emory University | HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine |
US7115584B2 (en) | 1999-01-22 | 2006-10-03 | Emory University | HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine |
US7427606B2 (en) * | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
US7378400B2 (en) * | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
YU25500A (sh) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Postupak za sintezu analoga nukleozida |
US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
DE60011637T2 (de) * | 1999-09-24 | 2004-11-11 | Shire Biochem Inc., Laval | Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen |
US6566365B1 (en) | 1999-11-04 | 2003-05-20 | Biochem Pharma Inc. | Method for the treatment of Flaviviridea viral infection using nucleoside analogues |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
CA2308559C (en) * | 2000-05-16 | 2005-07-26 | Brantford Chemicals Inc. | 1,3-oxathiolan-5-ones useful in the production of antiviral nucleoside analogues |
DK1389207T3 (da) * | 2001-03-01 | 2006-04-18 | Gilead Sciences Inc | Polymorfe og andre krystallinske former af cis-FTC |
CA2351049C (en) | 2001-06-18 | 2007-03-13 | Brantford Chemicals Inc. | Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers |
AU2002362443B2 (en) * | 2001-10-01 | 2008-05-15 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
SI1436321T1 (sl) | 2001-10-19 | 2006-12-31 | Isotechnika Inc | Sinteza analogov ciklosporina |
ITMI20012317A1 (it) * | 2001-11-06 | 2003-05-06 | Recordati Ind Chimica E Farma | Processo diastereoselettivo per la preparazione del'agente antivirale4-amino-1-(2r-idrossimetil-/1,3/ossatiolan-5s-i1)-1h-pirimidin-2-one |
EP1461041A4 (en) * | 2001-12-14 | 2006-03-29 | Pharmasset Ltd | PREPARATION OF INTERMEDIATES SUITABLE FOR THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES |
US20050085638A1 (en) | 2002-01-25 | 2005-04-21 | Shire Biochem Inc | Process for producing dioxolane nucleoside analogues |
US7365173B2 (en) * | 2002-02-04 | 2008-04-29 | American National Red Cross | Method for the production of pure virally inactivated butyrylcholinesterase |
KR101108115B1 (ko) | 2002-08-06 | 2012-01-31 | 파마셋 인코포레이티드 | 1,3-디옥솔란 뉴클레오사이드의 제조 방법 |
KR20090053867A (ko) | 2003-01-14 | 2009-05-27 | 길리애드 사이언시즈, 인코포레이티드 | 복합 항바이러스 치료를 위한 조성물 및 방법 |
ITMI20030578A1 (it) * | 2003-03-24 | 2004-09-25 | Clariant Lsm Italia Spa | Processo ed intermedi per la preparazione di emtricitabina |
KR101157468B1 (ko) | 2004-02-03 | 2012-07-06 | 에모리 유니버시티 | 1,3-디옥솔란 뉴클레오시드 제조방법 |
WO2006023272A1 (en) * | 2004-08-02 | 2006-03-02 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
WO2006028618A1 (en) * | 2004-08-02 | 2006-03-16 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity |
US7605143B2 (en) * | 2004-08-02 | 2009-10-20 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs with modified 5′-ribose groups having A2A agonist activity |
US7727194B2 (en) * | 2004-08-31 | 2010-06-01 | Ethicon Endo-Surgery, Inc. | Drug delivery cassette |
US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
TWI375560B (en) | 2005-06-13 | 2012-11-01 | Gilead Sciences Inc | Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same |
TWI471145B (zh) | 2005-06-13 | 2015-02-01 | Bristol Myers Squibb & Gilead Sciences Llc | 單一式藥學劑量型 |
US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
WO2007077505A2 (en) * | 2005-12-30 | 2007-07-12 | Ranbaxy Laboratories Limited | Crystalline l-menthyl (2r, 5s)-5-(4-amino-5-fluoro-2-oxo-2h-pyrimidin-1-yl)[1, 3]oxathiolan-2-carboxylate and process for preparation thereof |
WO2007120972A2 (en) * | 2006-02-10 | 2007-10-25 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
US8188063B2 (en) * | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
US20110257396A1 (en) * | 2006-10-30 | 2011-10-20 | Lupin Limited | Process for the manufacture of cis(-)-lamivudine |
BRPI0817269A2 (pt) | 2007-09-26 | 2014-10-07 | Sinai School Medicine | Análogos de azacitidina e usos dos mesmos |
US20100311970A1 (en) * | 2007-11-29 | 2010-12-09 | Ranbaxy Laboratories Limited | Process for the preparation of substituted 1,3-oxathiolanes |
AU2008331167A1 (en) * | 2007-11-29 | 2009-06-04 | Ranbaxy Laboratories Limited | Process and intermediates for the preparation of substituted 1, 3-oxathiolanes, especially lamivudine |
US8350030B2 (en) | 2007-12-07 | 2013-01-08 | Matrix Laboratories Limited | Process for producing 5-fluoro-1-(2R, 5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
US8058259B2 (en) * | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
MX2010011963A (es) | 2008-05-02 | 2010-12-06 | Gilead Sciences Inc | Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico. |
WO2010082128A1 (en) | 2009-01-19 | 2010-07-22 | Aurobindo Pharma Limited | Process for the preparation of cis-nucleoside derivative |
AU2010210598B2 (en) | 2009-02-06 | 2015-03-05 | Gilead Sciences, Inc. | Tablets for combination therapy |
EP2521729A4 (en) * | 2010-01-08 | 2013-07-31 | Hetero Research Foundation | IMPROVED METHOD FOR NUCLEOSIDES |
ES2969969T3 (es) | 2010-01-27 | 2024-05-23 | Viiv Healthcare Co | Combinaciones de dolutegravir y lamivudina para el tratamiento de la infección por VIH |
US20120295930A1 (en) * | 2010-02-03 | 2012-11-22 | Shankar Rama | Novel process for the preparation of cis-nucleoside derivative |
AU2011222471B2 (en) | 2010-03-04 | 2014-07-31 | Sun Pharmaceutical Industries Limited | A process for stereoselective synthesis of 5-fluoro-1-(2R,5S)-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine |
EP2377862A1 (en) | 2010-03-29 | 2011-10-19 | Esteve Química, S.A. | Process for obtaining emtricitabine |
WO2011141805A2 (en) | 2010-05-14 | 2011-11-17 | Lupin Limited | An improved process for the manufacture of lamivudine |
WO2012062835A1 (en) | 2010-11-12 | 2012-05-18 | Glaxo Wellcome Manufacturing Pte Ltd | Novel pharmaceutical compositions |
US20130296562A1 (en) | 2011-08-05 | 2013-11-07 | Lupin Limited | Stereoselective process for preparation of 1,3-oxathiolane nucleosides |
MX359314B (es) | 2011-08-30 | 2018-09-25 | Astex Pharmaceuticals Inc Star | Formulaciones derivadas de decitabina. |
CN103242243B (zh) * | 2013-01-08 | 2015-08-19 | 北京大学 | 一种碱基乙酸甘油醚酯分子,其化学合成方法及其在基因治疗领域的应用 |
CN103288806A (zh) * | 2013-07-02 | 2013-09-11 | 山东大学 | 一种曲沙他滨的合成方法 |
RU2723590C2 (ru) | 2015-07-02 | 2020-06-16 | Оцука Фармасьютикал Ко., Лтд. | Лиофилизированные фармацевтические композиции |
CN105037340B (zh) * | 2015-07-14 | 2018-08-10 | 福建广生堂药业股份有限公司 | 一种拉米夫定关键中间体手性异构体杂质的制备方法 |
KR20200035438A (ko) | 2017-08-03 | 2020-04-03 | 오쓰까 세이야꾸 가부시키가이샤 | 약물 화합물 및 이의 정제 방법 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1445013A (fr) * | 1964-07-09 | 1966-07-08 | Thomae Gmbh Dr K | Procédé pour fabriquer des nouveaux acides dioxolano-2-carboxyliques |
US4383114A (en) * | 1977-02-09 | 1983-05-10 | Regents Of The University Of Minnesota | Adenosine deaminase resistant antiviral purine arabinonucleosides |
US4231945A (en) * | 1978-11-08 | 1980-11-04 | Schering Corporation | S-5-(Azidomethyl or aminomethyl)-2-lower-alkoxytetrahydrofurans |
US4479942A (en) * | 1981-08-10 | 1984-10-30 | Fujisawa Pharmaceutical Co., Ltd. | Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof |
US4855304A (en) * | 1985-01-10 | 1989-08-08 | Repligen Corporation | Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals |
DK363987A (da) * | 1986-08-08 | 1988-02-09 | Hoffmann La Roche | Pyrimidinderivater |
GB8621268D0 (en) * | 1986-09-03 | 1986-10-08 | Univ Strathclyde | Separation of substances |
US4997818A (en) * | 1987-09-21 | 1991-03-05 | The University Hospital | Therapeutic method for selectively treating terminal deoxynucleotidyl transferase-positive neoplastic leukemias and lymphomas |
SE8704298D0 (sv) * | 1987-11-03 | 1987-11-03 | Astra Ab | Compounds for use in therapy |
US4997926A (en) * | 1987-11-18 | 1991-03-05 | Scripps Clinic And Research Foundation | Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy |
JPH022349A (ja) * | 1988-02-17 | 1990-01-08 | Takeda Chem Ind Ltd | ピリミジンアナログ耐性化遺伝子dnaおよびその用途 |
NZ228645A (en) * | 1988-04-11 | 1991-09-25 | Iaf Biochem Int | 1,3-dioxolane derivatives substituted in the 5th position by a purine or pyrimidine radical; treatment of viral infections |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
GB8815265D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Therapeutic nucleosides |
DE3823127A1 (de) * | 1988-07-08 | 1990-01-11 | Rheinische Braunkohlenw Ag | Vorrichtung und verfahren zur reinigung von abwasser |
US4987224A (en) * | 1988-08-02 | 1991-01-22 | University Of Georgia Research Foundation, Inc. | Method of preparation of 2',3'-dideoxynucleosides |
DE3827134A1 (de) * | 1988-08-10 | 1990-03-15 | Bayer Ag | Substituierte triazolyl- bzw. imidazolyl-hydroxyalkyldioxolane, verfahren zu ihrer herstellung und ihre verwendung als mikrobizide, oxiranyldioxolane, dioxolanylketone, oxiranylketone und (alpha)-halogenketone als zwischenprodukte und verfahren zu deren herstellung |
US5075225A (en) * | 1989-04-06 | 1991-12-24 | The Texas A&M University System | Process for the enzymatic synthesis of nucleosides |
NZ233197A (en) * | 1989-04-13 | 1991-11-26 | Richard Thomas Walker | Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions |
IE902574A1 (en) * | 1989-07-17 | 1991-02-27 | Univ Birmingham | Antiviral pyrimidine nucleosides |
IE904378A1 (en) * | 1989-12-20 | 1991-07-03 | Abbott Lab | Analogs of oxetanyl purines and pyrimidines |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
GB9014090D0 (en) * | 1990-06-25 | 1990-08-15 | Zaadunie Bv | Improvements in or relating to organic compounds |
AU9125991A (en) * | 1990-12-05 | 1992-07-08 | University Of Georgia Research Foundation, Inc., The | Enantiomerically pure beta -l-(-)-1,3-oxathiolane nucleosides |
NZ250842A (en) * | 1991-02-22 | 1996-03-26 | Univ Emory | Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc) |
WO1992018517A1 (en) * | 1991-04-17 | 1992-10-29 | Yale University | Method of treating or preventing hepatitis b virus |
GB9109506D0 (en) * | 1991-05-02 | 1991-06-26 | Wellcome Found | Therapeutic nucleosides |
ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
-
1992
- 1992-05-19 ZA ZA923641A patent/ZA923641B/xx unknown
- 1992-05-19 ZA ZA923640A patent/ZA923640B/xx unknown
- 1992-05-20 HU HU9303296A patent/HU223838B1/hu not_active IP Right Cessation
- 1992-05-20 CZ CZ932492A patent/CZ285220B6/cs not_active IP Right Cessation
- 1992-05-20 IL IL116176A patent/IL116176A/en not_active IP Right Cessation
- 1992-05-20 KR KR1019920008694A patent/KR100232012B1/ko not_active IP Right Cessation
- 1992-05-20 NO NO921989A patent/NO300593B1/no unknown
- 1992-05-20 NZ NZ242817A patent/NZ242817A/en not_active IP Right Cessation
- 1992-05-20 IL IL101932A patent/IL101932A/xx not_active IP Right Cessation
- 1992-05-20 RU RU99115480/04A patent/RU2223960C2/ru active
- 1992-05-20 AU AU16913/92A patent/AU1691392A/en not_active Abandoned
- 1992-05-20 DK DK92304552.0T patent/DK0515157T3/da active
- 1992-05-20 RU RU93058554A patent/RU2105009C1/ru not_active IP Right Cessation
- 1992-05-20 HU HU9303297A patent/HU221850B1/hu active IP Right Grant
- 1992-05-20 SK SK1293-93A patent/SK279438B6/sk not_active IP Right Cessation
- 1992-05-20 WO PCT/CA1992/000209 patent/WO1992020696A1/en active IP Right Grant
- 1992-05-20 AT AT92304552T patent/ATE157662T1/de active
- 1992-05-20 AT AT92304551T patent/ATE133958T1/de not_active IP Right Cessation
- 1992-05-20 RU RU96119766/04A patent/RU2163909C2/ru not_active IP Right Cessation
- 1992-05-20 IL IL11610992A patent/IL116109A/en not_active IP Right Cessation
- 1992-05-20 WO PCT/CA1992/000211 patent/WO1992020669A1/en active IP Right Grant
- 1992-05-20 CA CA002069024A patent/CA2069024C/en not_active Expired - Fee Related
- 1992-05-20 CZ CZ932493A patent/CZ280857B6/cs not_active IP Right Cessation
- 1992-05-20 DE DE69221936T patent/DE69221936T2/de not_active Expired - Lifetime
- 1992-05-20 NZ NZ242818A patent/NZ242818A/en not_active IP Right Cessation
- 1992-05-20 AU AU16395/92A patent/AU668086B2/en not_active Ceased
- 1992-05-20 CA CA002069063A patent/CA2069063C/en not_active Expired - Lifetime
- 1992-05-20 PL PL92309052A patent/PL176026B1/pl unknown
- 1992-05-20 SG SG1996003228A patent/SG43863A1/en unknown
- 1992-05-20 ES ES92304552T patent/ES2104832T3/es not_active Expired - Lifetime
- 1992-05-20 PL PL92301339A patent/PL168910B1/pl not_active IP Right Cessation
- 1992-05-20 US US08/142,389 patent/US5756706A/en not_active Expired - Fee Related
- 1992-05-20 KR KR1019920008507A patent/KR0160144B1/ko not_active IP Right Cessation
- 1992-05-20 EP EP92304551A patent/EP0515156B1/en not_active Expired - Lifetime
- 1992-05-20 NO NO921988A patent/NO301010B1/no not_active IP Right Cessation
- 1992-05-20 DK DK92304551.2T patent/DK0515156T3/da active
- 1992-05-20 IL IL10193192A patent/IL101931A/en not_active IP Right Cessation
- 1992-05-20 PL PL92301340A patent/PL170869B1/pl unknown
- 1992-05-20 SK SK1294-93A patent/SK281954B6/sk not_active IP Right Cessation
- 1992-05-20 RO RO93-01554A patent/RO116812B1/ro unknown
- 1992-05-20 EP EP92304552A patent/EP0515157B1/en not_active Expired - Lifetime
- 1992-05-20 ES ES92304551T patent/ES2084937T3/es not_active Expired - Lifetime
- 1992-05-20 RU RU93058362A patent/RU2140925C1/ru active
- 1992-05-20 MD MD95-0172A patent/MD1155C2/ro unknown
- 1992-05-20 CZ CZ962224A patent/CZ222496A3/cs not_active IP Right Cessation
- 1992-05-20 DE DE69208144T patent/DE69208144T2/de not_active Expired - Fee Related
- 1992-05-20 AU AU16394/92A patent/AU655973B2/en not_active Expired
- 1992-05-20 AU AU16908/92A patent/AU1690892A/en not_active Abandoned
- 1992-05-21 CN CN92103921A patent/CN1038591C/zh not_active Expired - Lifetime
- 1992-05-21 JP JP12915592A patent/JP3229013B2/ja not_active Expired - Lifetime
- 1992-05-21 US US08/142,387 patent/US5696254A/en not_active Expired - Lifetime
- 1992-05-21 MX MX9202404A patent/MX9202404A/es unknown
- 1992-05-21 JP JP12916392A patent/JP3330972B2/ja not_active Expired - Fee Related
- 1992-05-21 MX MX9202395A patent/MX9202395A/es unknown
- 1992-05-21 CN CN92103924A patent/CN1035555C/zh not_active Expired - Fee Related
- 1992-06-02 TW TW081104321A patent/TW366349B/zh not_active IP Right Cessation
- 1992-06-02 TW TW088109374A patent/TW467907B/zh not_active IP Right Cessation
- 1992-06-02 TW TW081104323A patent/TW366350B/zh not_active IP Right Cessation
- 1992-06-02 TW TW088109433A patent/TWI245046B/zh not_active IP Right Cessation
- 1992-07-01 IE IE921619A patent/IE76741B1/en not_active IP Right Cessation
- 1992-07-01 IE IE161892A patent/IE921618A1/en not_active IP Right Cessation
-
1993
- 1993-11-19 FI FI935151A patent/FI106377B/fi not_active IP Right Cessation
- 1993-11-19 FI FI935150A patent/FI109025B/fi active
- 1993-11-19 OA OA60440A patent/OA10212A/en unknown
- 1993-12-20 BG BG98310A patent/BG61695B1/bg unknown
- 1993-12-20 BG BG98311A patent/BG61696B1/bg unknown
-
1994
- 1994-10-20 EE EE9400283A patent/EE03044B1/xx unknown
-
1995
- 1995-03-10 CN CN95102412A patent/CN1050603C/zh not_active Expired - Lifetime
- 1995-06-05 US US08/464,960 patent/US5744596A/en not_active Expired - Fee Related
- 1995-06-05 US US08/460,856 patent/US5663320A/en not_active Expired - Lifetime
- 1995-06-05 US US08/464,317 patent/US5693787A/en not_active Expired - Lifetime
- 1995-11-23 IL IL11610995A patent/IL116109A0/xx unknown
- 1995-11-28 IL IL11617695A patent/IL116176A0/xx unknown
-
1996
- 1996-02-08 GR GR960400299T patent/GR3018941T3/el unknown
- 1996-07-18 HK HK132196A patent/HK132196A/xx not_active IP Right Cessation
-
1997
- 1997-09-04 GR GR970400204T patent/GR3024617T3/el unknown
-
1998
- 1998-02-24 HK HK98101405A patent/HK1002431A1/xx not_active IP Right Cessation
- 1998-03-04 GT GT199800047A patent/GT199800047A/es unknown
- 1998-12-03 CN CN98122383A patent/CN1109030C/zh not_active Expired - Lifetime
- 1998-12-03 CN CN98122385A patent/CN1083450C/zh not_active Expired - Lifetime
- 1998-12-03 CN CN98122384A patent/CN1097049C/zh not_active Expired - Lifetime
-
1999
- 1999-07-12 KR KR1019990027976A patent/KR100242921B1/ko not_active IP Right Cessation
-
2000
- 2000-08-29 FI FI20001900A patent/FI20001900A/fi unknown
-
2001
- 2001-05-07 JP JP2001136217A patent/JP3704055B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116176A0 (en) | Intermediate compounds for the diastereoselective synthesis of cis-nucleoside analogues | |
RU93058362A (ru) | Способы диастереоселективного синтеза нуклеозидов, промежуточные соединения, способы получения промежуточных соединений | |
RU93058554A (ru) | Способы диастереоселективного синтеза нуклеозидов | |
HU9403467D0 (en) | Improved process for producing bis-indolyl-maleimide derivatives | |
IL89048A (en) | Process for the preparation of 16-methyl-16-methoxy- prostaglandin e1 derivatives and intermediate therefor |